PCSK9 Inhibitors and Bipolar Disorder: A Drug Target Mendelian Randomization Study. [PDF]
Clin NeuropharmacolLi J, Yao PS.
europepmc +1 more source
Therapeutic Potential of PCSK9 Inhibitors in Regulating Neuroinflammation in Acute Ischemic Stroke. [PDF]
CNS DrugsPu L +6 more
europepmc +1 more source
PCSK9 Inhibitors Increase CD34+ But Not Other Endothelial Progenitor Cells in Patients with Chronic Coronary Disease and Increased Lp(a) Values. [PDF]
TH OpenUgovšek S +11 more
europepmc +1 more source
Impact of PCSK9 Inhibitors on Lipoprotein(a) Levels: A Multi-Center Study. [PDF]
Eur J Prev CardiolBhatia HS +5 more
europepmc +1 more source
Knowledge, Attitudes, and Practices Regarding PCSK9 Inhibitors Among Healthcare Professionals: Exploring Behavioral Pathways and the Intermediary Role of Attitude. [PDF]
J Multidiscip HealthcZhao C, Wang N, Shen D, Zhu L, Chen G.
europepmc +1 more source
Naturally Occurring PCSK9 Inhibitors: An Updated Review. [PDF]
MoleculesHuh J, Kim H.
europepmc +1 more source
PCSK9 inhibitors: a promising lipid-lowering strategy for kidney transplant recipients. [PDF]
Ren FailLuo B, Guo L, Di W.
europepmc +1 more source
Effects of PCSK9 inhibitors on coronary atheroma morphology in patients with coronary artery disease treated with statins: a meta-analysis and systematic review. [PDF]
Am J Prev CardiolThakurathi P +9 more
europepmc +1 more source
The lipid lowering efficacy of PCSK9 inhibitors alone vs. statins alone: a meta-analysis. [PDF]
Front Cardiovasc MedKyan K, Gornbein J, Saver J.
europepmc +1 more source